Ignite Creation Date:
2025-12-24 @ 10:00 PM
Ignite Modification Date:
2026-01-13 @ 7:39 PM
Study NCT ID:
NCT00359632
Status:
TERMINATED
Last Update Posted:
2015-06-26
First Post:
2006-07-28
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study to Evaluate Eye Function in Patients Taking Linezolid for Six Weeks or Greater
Sponsor:
Pfizer
Organization:
Study Overview
Official Title:
Prospective Study Of Ophthalmologic Function In Patients Receiving Linezolid For Six Weeks Or Greater
Status:
TERMINATED
Status Verified Date:
2015-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Study was stopped due to poor enrollment on 28 Feb 2012. Reason for termination was not due to safety concerns.
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To understand and characterize the effects of linezolid on the optic nerve by observing and following patients who have been treated with linezolid for six weeks or longer for the development of signs or symptoms of visual disturbance or eye disorders.
Detailed Description:
Characterize Optic Side Effect
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
Secondary ID Infos
| Secondary ID | Type | Domain | Link | View |
|---|---|---|---|---|
| 2006-002303-14 | EUDRACT_NUMBER | None | View |